# Translational Research in Oncology

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/translational-research-in-oncology/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 67 |
| Citations | 323,492 |
| City | Paris |
| Country | FR |
| Description | Translational Research in Oncology is a research organisation in Paris, FR. OpenAlex records 2,736 works and 323,492 citations for it. 843 researchers list it as their most recent affiliation. |
| Homepage | https://trioncology.org |
| OpenAlex ID | https://openalex.org/I4210110449 |
| Region | Île-de-France |
| Researchers | 843 |
| ROR ID | https://ror.org/01yqkfx81 |
| Type | nonprofit |
| Works | 2,736 |

## University papers

- [Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases](https://scholariq.org/papers/chemotherapy-regimen-predicts-steatohepatitis-and-an-increase-in-90-day/)
- [Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer/)
- [Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas](https://scholariq.org/papers/fluorouracil-doxorubicin-and-streptozocin-in-the-treatment-of-patients-with/)
- [Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance](https://scholariq.org/papers/phase-ii-trial-of-infusional-fluorouracil-irinotecan-and-bevacizumab-for/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.